Bruker (BRKR)
(Delayed Data from NSDQ)
$65.88 USD
-2.45 (-3.59%)
Updated Aug 2, 2024 04:00 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Bruker Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 428.50 | 298.50 | 280.60 | 161.40 | 198.00 |
Depreciation/Amortization & Depletion | 114.90 | 88.80 | 89.10 | 80.40 | 75.60 |
Net Change from Assets/Liabilities | -87.80 | -144.10 | -125.60 | 69.60 | -74.50 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -105.50 | 31.20 | 38.30 | 20.80 | 14.30 |
Net Cash From Operating Activities | 350.10 | 274.40 | 282.40 | 332.20 | 213.40 |
Property & Equipment | -95.80 | -115.30 | -87.10 | -97.00 | -62.00 |
Acquisition/ Disposition of Subsidiaries | -226.60 | -182.30 | -65.00 | -59.20 | -90.00 |
Investments | -24.80 | 39.80 | -50.30 | -45.10 | -6.40 |
Other Investing Activities | 21.20 | 6.20 | 10.00 | 8.60 | 0.00 |
Net Cash from Investing Activities | -326.00 | -251.60 | -192.40 | -192.70 | -158.40 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -142.80 | -260.30 | -146.30 | -119.90 | -131.40 |
Issuance (Repayment) of Debt | -6.50 | 0.00 | 492.00 | 0.00 | 593.30 |
Increase (Decrease) Short-Term Debt | -15.00 | -111.00 | -2.30 | -8.30 | -126.30 |
Payment of Dividends & Other Distributions | -29.40 | -29.80 | -24.20 | -24.60 | 0.00 |
Other Financing Activities | 0.30 | -14.20 | -0.50 | -8.80 | -35.60 |
Net Cash from Financing Activities | -193.40 | -415.30 | 318.70 | -161.60 | 300.00 |
Effect of Exchange Rate Changes | 12.20 | -30.50 | -22.50 | 25.70 | 0.60 |
Net Change In Cash & Equivalents | -157.10 | -423.00 | 386.20 | 3.60 | 355.60 |
Cash at Beginning of Period | 648.70 | 1,071.70 | 685.50 | 681.90 | 326.30 |
Cash at End of Period | 491.60 | 648.70 | 1,071.70 | 685.50 | 681.90 |
Diluted Net EPS | 2.90 | 1.99 | 1.81 | 1.02 | 1.26 |
Fiscal Year End for Bruker Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 52.00 | 428.50 | 223.90 | 135.20 |
Depreciation/Amortization & Depletion | NA | 34.70 | 114.90 | 77.60 | 51.00 |
Net Change from Assets/Liabilities | NA | -63.40 | -87.80 | -209.10 | -125.10 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -1.50 | -105.50 | 52.20 | 39.40 |
Net Cash From Operating Activities | NA | 21.80 | 350.10 | 144.60 | 100.50 |
Property & Equipment | NA | -20.90 | -95.80 | -64.50 | -37.80 |
Acquisition/ Disposition of Subsidiaries | NA | -274.50 | -226.60 | -222.30 | -102.70 |
Investments | NA | -10.00 | -24.80 | -7.50 | 2.50 |
Other Investing Activities | NA | 1.20 | 21.20 | 5.10 | 3.80 |
Net Cash from Investing Activities | NA | -304.20 | -326.00 | -289.20 | -134.20 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 3.40 | -142.80 | -97.10 | -19.60 |
Issuance (Repayment) of Debt | NA | -3.40 | -6.50 | 3.20 | 2.80 |
Increase (Decrease) Short-Term Debt | NA | 164.60 | -15.00 | -11.30 | -7.50 |
Payment of Dividends & Other Distributions | NA | -7.30 | -29.40 | -22.10 | -14.70 |
Other Financing Activities | NA | -5.60 | 0.30 | -6.20 | -2.00 |
Net Cash from Financing Activities | NA | 151.70 | -193.40 | -133.50 | -41.00 |
Effect of Exchange Rate Changes | NA | -17.60 | 12.20 | -3.70 | 4.20 |
Net Change In Cash & Equivalents | NA | -148.30 | -157.10 | -281.80 | -70.50 |
Cash at Beginning of Period | NA | 491.60 | 648.70 | 648.70 | 648.70 |
Cash at End of Period | NA | 343.30 | 491.60 | 366.90 | 578.20 |
Diluted Net EPS | NA | 0.35 | 1.39 | 0.60 | 0.39 |